GNL3L

GNL3L is a nucleolar GTPase of the HSR1/MMR1 family that functions as a central regulator of ribosome biogenesis and cell cycle progression. Its GTPase activity, driven by circularly permuted G-motifs, is required for pre-60S rRNA processing, 60S subunit maintenance, and protein synthesis, while a lysine-rich nucleolar localization signal and GTP binding cooperate for nucleolar retention (PMID:16251348, PMID:41755636, PMID:17034816). In the nucleoplasm, GNL3L stabilizes TRF1 by blocking FBX4-mediated ubiquitylation to promote the metaphase-to-anaphase transition, and stabilizes MDM2 by preventing its ubiquitylation to suppress p53 target gene expression and G2/M arrest (PMID:19487455, PMID:21132010). GNL3L additionally inhibits ERRγ transcription by competing with SRC coactivators, activates NF-κB signaling through modulation of p65, and promotes autophagy via the AMPK pathway (PMID:17623774, PMID:27764577, PMID:38148364).

1. 2005 High

   Establishing that GNL3L is required for pre-rRNA processing and ribosomal protein export answered the fundamental question of its ancestral cellular function — ribosome biogenesis — and showed conservation from fission yeast to human.

   Evidence siRNA knockdown in HeLa cells plus genetic rescue of Δgrn1 yeast with human GNL3L, Northern blot for rRNA, and ribosomal protein export assays

   PMID:16251348

   Open questions at the time

   • Precise step in ribosome assembly where GNL3L acts was not resolved
   • Whether GTPase activity per se was required for rRNA processing was untested
2. 2006 High

   Identification of a lysine-rich NoLS (aa 1–50) and the requirement of GTP binding for nucleolar retention defined the dual-signal mechanism governing GNL3L subnuclear targeting.

   Evidence Deletion/point mutagenesis, importin-β Co-IP, intracellular GTP depletion, heterologous targeting assays

   PMID:17034816

   Open questions at the time

   • Whether importin-β interaction is direct or bridged by an adaptor was not distinguished
   • Mechanism of GTP-dependent retention (tethering to rDNA vs. pre-ribosomal particles) was unknown
3. 2007 High

   Discovery that GNL3L inhibits ERRγ transcription by competing with SRC coactivators for ERRγ AF2-domain binding revealed a nucleoplasmic transcriptional regulatory function independent of nucleolar localization.

   Evidence Co-IP with domain mapping, SRC competition assay, transcriptional reporter in mammalian cells

   PMID:17623774

   Open questions at the time

   • Physiological context triggering GNL3L–ERRγ interaction was not identified
   • Whether this extends to other nuclear receptors was untested
4. 2009 High

   Demonstrating that GNL3L stabilizes TRF1 by blocking FBX4-mediated ubiquitylation and that this promotes the metaphase-to-anaphase transition established GNL3L as a cell-cycle-dependent regulator of telomere-binding protein homeostasis.

   Evidence Co-IP, in vivo ubiquitylation assay, live imaging, siRNA with mitotic phenotype readout in HeLa cells

   PMID:19487455

   Open questions at the time

   • How GNL3L itself is regulated during mitosis was unclear
   • Whether TRF1 stabilization affects telomere length maintenance long-term was not assessed
5. 2010 High

   Finding that GNL3L stabilizes MDM2 by preventing its ubiquitylation and thereby suppresses p53 target genes showed a second nucleoplasmic substrate-stabilizing mechanism, linking GNL3L to the p53 pathway.

   Evidence Co-IP, in vivo ubiquitylation assay, siRNA knockdown with cell cycle analysis and p53 reporter assay

   PMID:21132010

   Open questions at the time

   • How GNL3L discriminates between TRF1- and MDM2-stabilization contexts was unknown
   • Direct structural basis for MDM2 ubiquitylation blockade was not resolved
6. 2014 High

   Comparative loss-of-function analysis established that GNL3L retained the ancestral ribosome biogenesis function while its paralog nucleostemin diverged to genome protection, clarifying the functional split between the two HSR1/MMR1 family members.

   Evidence siRNA knockdown with ribosome production and DNA damage marker (γH2AX) assays in human cells

   PMID:24610951

   Open questions at the time

   • Whether GNL3L has any secondary DNA damage role under specific stresses remained untested
7. 2015 High

   Identification of a CRM1-dependent NES (aa 501–582) and demonstration that nuclear-retained GNL3L drives S-phase progression via Rb–E2F1 axis activation defined the export mechanism and revealed that nucleoplasmic GNL3L abundance controls cell cycle entry.

   Evidence Leptomycin B treatment, NES mutagenesis, CRM1 Co-IP, BrdU labeling, Western blot for Rb phosphorylation and cyclins

   PMID:26274615

   Open questions at the time

   • Whether CRM1 export is regulated by post-translational modification was not tested
   • How nuclear GNL3L promotes Rb hyperphosphorylation mechanistically was not defined
8. 2016 Medium

   Discovery that LDOC1 destabilizes GNL3L and that GNL3L activates NF-κB via p65 identified both a negative regulator and a pro-survival signaling output of GNL3L.

   Evidence Co-IP, overexpression/knockdown, NF-κB reporter assay, TNF-α stimulation, p65 siRNA epistasis

   PMID:27764577

   Open questions at the time

   • Mechanism by which LDOC1 destabilizes GNL3L (proteasomal vs. other) was not determined
   • How GNL3L modulates p65 levels was unexplored
9. 2023 Medium

   Linking GNL3L to AMPK-dependent autophagy in esophageal cancer cells expanded its functional repertoire beyond ribosome biogenesis and transcription factor stabilization.

   Evidence Gain/loss-of-function with autophagy markers, AMPK agonist rescue, genetic AMPK inhibition in ESCC cells

   PMID:38148364

   Open questions at the time

   • Direct physical interaction with AMPK or upstream kinase not demonstrated
   • Relevance to non-cancer autophagy contexts untested
10. 2025 Medium

    Epistasis experiments confirming GNL3L as an upstream regulator of the MDM2–p53–p21 axis in ESCC, and demonstration that NF-κB–Slug–MMP2/9 mediates GNL3L-driven invasion, consolidated its oncogenic signaling roles with in vivo validation.

    Evidence Co-IP, siRNA/overexpression rescue, in vivo xenografts in ESCC and lung cancer models

    PMID:40466800 PMID:40856423

    Open questions at the time

    • Whether GNL3L's ribosome biogenesis and oncogenic signaling functions are separable was not tested
    • Structural basis for GNL3L–MDM2 interaction remains unknown
11. 2026 High

    Structural and biochemical dissection of GNL3L on pre-60S particles showed that GTP binding and hydrolysis drive distinct pre-rRNA processing steps and that GTPase-inactive mutants accumulate on particles, providing the first mechanistic model for how GNL3L's enzymatic cycle promotes 60S biogenesis.

    Evidence Cryo-EM/compositional analysis of pre-ribosomal particles, GTPase-inactive mutants, RNA crosslinking, ribosome profiling

    PMID:41755636

    Open questions at the time

    • Full atomic-resolution structure of GNL3L on the pre-60S particle not yet available
    • Identity of the GTPase-activating factor for GNL3L is unknown

• How GNL3L's nucleolar ribosome biogenesis function is coordinated with its nucleoplasmic roles in TRF1/MDM2 stabilization and NF-κB activation, and whether these functions are mutually exclusive or simultaneously active, remains unresolved.
• No separation-of-function mutant isolating ribosome biogenesis from signaling roles
• Post-translational regulation of GNL3L partitioning between nucleolus and nucleoplasm is uncharacterized
• No structural model of full-length GNL3L with any nucleoplasmic partner